Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1995-3-6
|
pubmed:abstractText |
Very young children with central nervous system malignant brain tumors have a poor prognosis. As compared with older children, survival is less likely, and those children who do survive frequently have severe impairment of growth and cognitive abilities, resulting partly from treatment with radiotherapy. Therefore, an intensive chemotherapeutic regimen was used to treat children younger than 2 years of age with a diagnosis of malignant astrocytomas.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
75
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1045-50
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7842407-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7842407-Astrocytoma,
pubmed-meshheading:7842407-Central Nervous System Neoplasms,
pubmed-meshheading:7842407-Combined Modality Therapy,
pubmed-meshheading:7842407-Disease-Free Survival,
pubmed-meshheading:7842407-Female,
pubmed-meshheading:7842407-Humans,
pubmed-meshheading:7842407-Infant,
pubmed-meshheading:7842407-Male,
pubmed-meshheading:7842407-Survival Analysis
|
pubmed:year |
1995
|
pubmed:articleTitle |
Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group.
|
pubmed:affiliation |
Children's Hospital and Medical Center, Department of Pediatric Hematology-Oncology, Seattle, Washington.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Multicenter Study
|